Evidence suggests that parallel biochemical and regulatory processes occur during normal development and following various forms of central nervous system (CNS) injury. Among these, areas of particular interest are: (1) identification of CNS neurotrophic factors; and (2) the analysis of the regulation of neurotrophic factor and neuropeptide gene expression during development and in response to injury. Studies are underway to identify trophic factors produced in specific model systems, since recent evidence demonstrates the existence of numerous different neurotrophic factors. 6-OHDA-lesioned rats represent a Parkinsonian-like model in which changes in nerve growth factor, brain-derived neurotrophic factor and NT-3 are being examined at the level of mRNA, protein, and biologic activity. Since astrocytes can synthesis a number of neurotrophic factors, primary cultures of astrocytes are used to determine factors which regulate production of these potential trophic factors. Reactive astrocytes are prepared from 6-OHDA-lesioned brain: monoclonal antibodies raised against epitopes expressed only by reactive astrocytes in vivo can distinguish between normal adult and reactive astrocytes in culture. Astrocytes from newborn animals more closely resemble reactive astrocytes in terms of expression of these epitopes. Production of trophic factors by these reactive astrocytes is compared to that of control astrocytes to determine how injury may alter the regulatory pathways. Cytokines, produced at high levels in injured brain, induce expression of neurotrophic factors as well as of nitric oxide synthase, which may be responsible for some of the neuronal damage. Depletion of the cytokine interleukin-3 (IL-3) by an antisense construct results in transgenic mice expressing a neurologic syndrome. The lesion results from migration/activation of microglia in the cerebellar peduncle. Among novel enkephalin and somatostatin, both produced by astrocytes, have been demonstrated in culture as well as in transgenic mice. Enkephalin acts as a negative modulator of CNS development while somatostatin is a positive trophic factor. A retinal pigment epithelium-derived factor (PEDF) not only functions as a survival factor for cerebellar granule cell neurons but also can protect them against both glutamate toxicity and apoptotic cell death. In addition, PEDF activates microglia, which produce an as yet unidentified factor which inhibits astrocyte proliferation and may thus be useful in situations of gliosis due to astrocyte division.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS002752-10
Application #
2579571
Study Section
Special Emphasis Panel (CNB)
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Yabe, T; Wilson, D; Schwartz, J P (2001) NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem 276:43313-9
Nomura, T; Yabe, T; Mochizuki, H et al. (2001) Survival effects of pigment epithelium-derived factor expressed by a lentiviral vector in rat cerebellar granule cells. Dev Neurosci 23:145-52
Krzan, M; Wu, V W; Schwartz, J P (2001) Serotonin regulation of nerve growth factor synthesis in neonatal and adult astrocytes: comparison to the beta-adrenergic agonist isoproterenol. J Neurosci Res 64:261-7
Wu, V W; Mo, Q; Yabe, T et al. (2001) Perinatal opioids reduce striatal nerve growth factor content in rat striatum. Eur J Pharmacol 414:211-4
Chronwall, B M; Sands, S A; Cummings 3rd, K C et al. (2000) Glial somatostatin-14 expression in the rat pituitary intermediate lobe: a possible neurotrophic function during development? Int J Dev Neurosci 18:685-92
Cohen, J; Sugita, Y; Chader, G J et al. (2000) Recombinant forms of the neurotrophic factor pigment epithelium-derived factor activate cellular metabolism and inhibit proliferation of the RAW macrophage cell line. Neuroimmunomodulation 7:51-8
Nomura, T; Yabe, T; Rosenthal, E S et al. (2000) PSA-NCAM distinguishes reactive astrocytes in 6-OHDA-lesioned substantia nigra from those in the striatal terminal fields. J Neurosci Res 61:588-96
Sugita, Y; Zhao, B; Shankar, P et al. (1999) CNS interleukin-3 (IL-3) expression and neurological syndrome in antisense-IL-3 transgenic mice. J Neuropathol Exp Neurol 58:480-8
Kawamura, M; Schwartz, J P; Nomura, T et al. (1999) Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats. Neurochem Res 24:25-32